← All organizations

Alizé Pharma

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

Last known activity

Jul 1, 2013

Acquired by Millendo Therapeutics, Inc. → Tempest Therapeutics on Dec 20, 2017

Timeline

2010s

Jun 1, 2015
Alizé Pharma— Founded
Dec 20, 2017
Millendo Therapeutics, Inc.— Acquired By

2020s

Mar 29, 2021
Tempest Therapeutics— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

Livoletide

Indications

Studied for

Recent trials (1)

NCT02040012Lead sponsorPhase 1Jul 1, 2013

Details

Founded: Ecully, FR Jun 1, 2015
Last known activity: Jul 1, 2013